150 related articles for article (PubMed ID: 35940235)
21. Impaired vasoconstriction and nitric oxide-mediated relaxation in pulmonary arteries of hypoxia- and monocrotaline-induced pulmonary hypertensive rats.
Mam V; Tanbe AF; Vitali SH; Arons E; Christou HA; Khalil RA
J Pharmacol Exp Ther; 2010 Feb; 332(2):455-62. PubMed ID: 19915069
[TBL] [Abstract][Full Text] [Related]
22. H
Hazzaa SM; Elsayed Arafat ESE; Abdo Ismail AE; Eltorgoman AEA; Abdelaziz SA; Kombr YFA; Zidan RA; Assar MF
Tissue Cell; 2021 Oct; 72():101550. PubMed ID: 33915356
[TBL] [Abstract][Full Text] [Related]
23. ACE2 activation confers endothelial protection and attenuates neointimal lesions in prevention of severe pulmonary arterial hypertension in rats.
Li G; Liu Y; Zhu Y; Liu A; Xu Y; Li X; Li Z; Su J; Sun L
Lung; 2013 Aug; 191(4):327-36. PubMed ID: 23652350
[TBL] [Abstract][Full Text] [Related]
24. Analysis of cardiovascular responses to the H2S donors Na2S and NaHS in the rat.
Yoo D; Jupiter RC; Pankey EA; Reddy VG; Edward JA; Swan KW; Peak TC; Mostany R; Kadowitz PJ
Am J Physiol Heart Circ Physiol; 2015 Aug; 309(4):H605-14. PubMed ID: 26071540
[TBL] [Abstract][Full Text] [Related]
25. [Effects of rosuvastatin on monocrotaline-induced pulmonary artery hypertension in rats].
Li XL; Guan RJ; Xu QH; Wu ZY
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Mar; 39(3):247-53. PubMed ID: 21609531
[TBL] [Abstract][Full Text] [Related]
26. H
Wu J; Pan W; Wang C; Dong H; Xing L; Hou J; Fang S; Li H; Yang F; Yu B
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31239370
[No Abstract] [Full Text] [Related]
27. Effects of atorvastatin and L-arginine treatments on electrical field stimulation-mediated relaxations in pulmonary arterial rings of monocrotaline-induced pulmonary hypertensive rats.
Ozturk EI; Uma S
J Cardiovasc Pharmacol; 2010 Nov; 56(5):498-505. PubMed ID: 20729759
[TBL] [Abstract][Full Text] [Related]
28. Prolonged administration of L-arginine ameliorates chronic pulmonary hypertension and pulmonary vascular remodeling in rats.
Mitani Y; Maruyama K; Sakurai M
Circulation; 1997 Jul; 96(2):689-97. PubMed ID: 9244244
[TBL] [Abstract][Full Text] [Related]
29. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.
Wang X; Yang Y; Yang D; Tong G; Lv S; Lin X; Chen C; Dong W
J Vasc Surg; 2016 Nov; 64(5):1468-1477. PubMed ID: 26527422
[TBL] [Abstract][Full Text] [Related]
30. Hydrogen sulfide-induced relaxation of resistance mesenteric artery beds of rats.
Cheng Y; Ndisang JF; Tang G; Cao K; Wang R
Am J Physiol Heart Circ Physiol; 2004 Nov; 287(5):H2316-23. PubMed ID: 15191893
[TBL] [Abstract][Full Text] [Related]
31. Imatinib attenuates monocrotaline pulmonary hypertension and has potent vasodilator activity in pulmonary and systemic vascular beds in the rat.
Pankey EA; Thammasiboon S; Lasker GF; Baber S; Lasky JA; Kadowitz PJ
Am J Physiol Heart Circ Physiol; 2013 Nov; 305(9):H1288-96. PubMed ID: 23997103
[TBL] [Abstract][Full Text] [Related]
32. Resveratrol prevents monocrotaline-induced pulmonary hypertension in rats.
Csiszar A; Labinskyy N; Olson S; Pinto JT; Gupte S; Wu JM; Hu F; Ballabh P; Podlutsky A; Losonczy G; de Cabo R; Mathew R; Wolin MS; Ungvari Z
Hypertension; 2009 Sep; 54(3):668-75. PubMed ID: 19597040
[TBL] [Abstract][Full Text] [Related]
33. [Effects of hydrogen sulfide on vascular inflammation in pulmonary hypertension induced by high pulmonary blood flow: experiment with rats].
Jin HF; Liang C; Liang JM; Tang CS; DU JB
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2235-9. PubMed ID: 19087668
[TBL] [Abstract][Full Text] [Related]
34. Cardiopulmonary protective effects of the selective FXR agonist obeticholic acid in the rat model of monocrotaline-induced pulmonary hypertension.
Vignozzi L; Morelli A; Cellai I; Filippi S; Comeglio P; Sarchielli E; Maneschi E; Vannelli GB; Adorini L; Maggi M
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):277-292. PubMed ID: 27425465
[TBL] [Abstract][Full Text] [Related]
35. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
[TBL] [Abstract][Full Text] [Related]
36. Resveratrol reverses monocrotaline-induced pulmonary vascular and cardiac dysfunction: a potential role for atrogin-1 in smooth muscle.
Paffett ML; Lucas SN; Campen MJ
Vascul Pharmacol; 2012; 56(1-2):64-73. PubMed ID: 22146233
[TBL] [Abstract][Full Text] [Related]
37. Telmisartan attenuates monocrotaline-induced pulmonary artery endothelial dysfunction through a PPAR gamma-dependent PI3K/Akt/eNOS pathway.
Li H; Lu W; Cai WW; Wang PJ; Zhang N; Yu CP; Wang DL; Liu BC; Sun W
Pulm Pharmacol Ther; 2014 Jun; 28(1):17-24. PubMed ID: 24269521
[TBL] [Abstract][Full Text] [Related]
38. Ormeloxifene, a selective estrogen receptor modulator, protects against pulmonary hypertension.
Abdulkareem AO; Tiwari P; Lone ZR; Iqbal H; Gupta S; Jha RK; Chanda D; Jagavelu K; Hanif K
Eur J Pharmacol; 2023 Mar; 943():175558. PubMed ID: 36731722
[TBL] [Abstract][Full Text] [Related]
39. Chrysin Alleviates Monocrotaline-Induced Pulmonary Hypertension in Rats Through Regulation of Intracellular Calcium Homeostasis in Pulmonary Arterial Smooth Muscle Cells.
Dong F; Zhang J; Chen X; Zhang S; Zhu L; Peng Y; Guo Z
J Cardiovasc Pharmacol; 2020 Jun; 75(6):596-602. PubMed ID: 32168153
[TBL] [Abstract][Full Text] [Related]
40. Altered pulmonary vascular smooth muscle responsiveness in monocrotaline-induced pulmonary hypertension.
Altiere RJ; Olson JW; Gillespie MN
J Pharmacol Exp Ther; 1986 Feb; 236(2):390-5. PubMed ID: 3080584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
